Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.6 SEK | -2.38% |
|
+2.71% | +9.56% |
Jul. 08 | Infant Bacterial Therapeutics AB Completes Clinical Development Program | CI |
May. 07 | Infant Bacterial Therapeutics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 12-12-31 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 22-09-18 |
Chief Operating Officer | 57 | 14-10-19 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 15-12-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 15-09-23 |
Chairman | 74 | 10-12-31 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 17-05-03 |
Director/Board Member | 63 | 18-05-14 | |
Eva Idén
BRD | Director/Board Member | 58 | 17-05-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 453,283 | 0 | 0 | 87.87 % |
Stock B | 1 | 13,018,137 | 11,837,506 ( 90.93 %) | 0 |
Company contact information
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.com![address Infant Bacterial Therapeutics AB(IBT B)](https://cdn.zonebourse.com/static/address/43344232.png)
Group companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+9.56% | 129M | |
+5.31% | 73.13B | |
+31.05% | 10.38B | |
+41.28% | 5.16B | |
-18.53% | 4.73B | |
+18.24% | 3.81B | |
+26.86% | 2.26B | |
-39.52% | 1.88B | |
-45.54% | 1.77B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- IBT B Stock
- Company Infant Bacterial Therapeutics AB